BiotechTube

Olmesartan medoxomil + Placebo

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Atherosclerosis

Conditions

Atherosclerosis

Trial Timeline

Jun 1, 2000 โ†’ Dec 1, 2004

NCT ID
NCT00382213

About Olmesartan medoxomil + Placebo

Olmesartan medoxomil + Placebo is a phase 3 stage product being developed by Daiichi Sankyo for Atherosclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00382213. Target conditions include Atherosclerosis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00382213Phase 3Completed

Competing Products

20 competing products in Atherosclerosis

See all competitors
ProductCompanyStageHype Score
Orforglipron + PlaceboEli LillyPhase 3
77
Pactimibe sulfateDaiichi SankyoPhase 2/3
65
PactimibeDaiichi SankyoPhase 2
52
Bempedoic acid + Ezetimibe + Rosuvastatin + AtorvastatinDaiichi SankyoPhase 3
77
Micronized 17B-estradiolJohnson & JohnsonPhase 2/3
65
Rosuvastatin + placebo + aspirin + placeboAstraZenecaApproved
85
Rosuvastatin + PlaceboAstraZenecaApproved
85
rosuvastatin + placeboAstraZenecaPhase 1
33
Rosuvastatin + PlaceboAstraZenecaPhase 1
33
Rosuvastatin + AtorvastatinAstraZenecaPhase 3
77
Rosuvastatin + PlaceboAstraZenecaPhase 3
77
Rosuvastatin (5mg๏ผŒ10mg๏ผŒ20mg) + Rosuvastatin 5mgAstraZenecaApproved
85
Vorapaxar + PlaceboMerckPhase 3
77
Vorapaxar + Placebo + Aspirin + ClopidogrelMerckPhase 2
52
Niacin/simvastatin compared to simvastatin alone at 2 dosesMerckApproved
85
lovastatinMerckPhase 2/3
65
Ezetimibe + PlaceboMerckApproved
85
Vorapaxar + PlaceboMerckPhase 3
77
NiaspanMerckPre-clinical
23
MK0633MerckPhase 2
52

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85